Effects of thiamine on cardiac function in patients with systolic heart failure: Systematic review and metaanalysis of randomized, double-blind, placebo-controlled trials

Ochsner Journal

Volumn 13, Issue 4, 2013, Pages 495-499

  DiNicolantonio, James J ^a,b   Lavie, Carl J ^c,d   Niazi, Asfandyar K ^e   O'Keefe, James H ^f   Hu, Tian ^g  

^a Wegmans Pharmacy   (United States)

^b SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^e SHIFA COLLEGE OF MEDICINE   (Pakistan)

^f UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^g TULANE UNIVERSITY   (United States)

Author keywords

Heart failure; Stroke volume; Thiamine deficiency

Indexed keywords

COCARBOXYLASE; FUROSEMIDE; PLACEBO; THIAMINE;

ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL; SYSTEMATIC REVIEW; SYSTOLIC HEART FAILURE; TREATMENT DURATION; TREATMENT RESPONSE; VITAMIN SUPPLEMENTATION;

EID: 84890389513     PISSN: 15245012     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. American Heart Association. Heart Disease and Stroke Statistics-2005 Update. Dallas, TX: American Heart Association; 2005.
2. Bonow RO, Bennett S, Casey DE Jr, et al; American Heart Association Task Force on Performance Measures (Writing Committee to Develop Heart Failure Clinical Performance Measures); Heart Failure Society of America. ACC/AHA clinical performance measures for adults with chronic heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Heart Failure Clinical Performance Measures) endorsed by the Heart Failure Society of America. J Am Coll Cardiol. 2005 Sep 20;46(6):1144-1178.
3. Massie BM, Shah NB. Evolving trends in the epidemiologic factors of heart failure: rationale for preventive strategies and comprehensive disease management. Am Heart J. 1997 Jun; 133(6):703-712.
4. Yui Y, Itokawa Y, Kawai C. Furosemide-induced thiamine deficiency. Cardiovasc Res. 1980 Sep;14(9):537-540.
5. Seligmann H, Halkin H, Rauchfleisch S, et al. Thiamine deficiency in patients with congestive heart failure receiving long-term furosemide therapy: a pilot study. Am J Med. 1991 Aug;91(2): 151-155.
6. Brady JA, Rock CL, Horneffer MR. Thiamin status, diuretic medications, and the management of congestive heart failure. J Am Diet Assoc. 1995 May;95(5):541-544.
7. Hanninen SA, Darling PB, Sole MJ, Barr A, Keith ME. The prevalence of thiamin deficiency in hospitalized patients with congestive heart failure. J Am Coll Cardiol. 2006 Jan 17;47(2): 354-361.
8. Zenuk C, Healey J, Donnelly J, Vaillancourt R, Almalki Y, Smith S. Thiamine deficiency in congestive heart failure patients receiving long term furosemide therapy. Can J Clin Pharmacol. 2003 Winter;10(4):184-188.
9. Shimon I, Almog S, Vered Z, et al. Improved left ventricular function after thiamine supplementation in patients with congestive heart failure receiving long-term furosemide therapy. Am J Med. 1995 May;98(5):485-490.
10. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009 Jul 21;339:b2700.
11. Schoenenberger AW, Schoenenberger-Berzins R, der Maur CA, Suter PM, Vergopoulos A, Erne P. Thiamine supplementation in symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled, cross-over pilot study. Clin Res Cardiol. 2012 Mar;101(3):159-164. Epub 2011 Nov 5.
12. Higgins JP, Thompson SG. Quantifying heterogeneity in a metaanalysis. Stat Med. 2002 Jun 15;21(11):1539-1558.
13. Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]. The Cochrane Collaboration. Hoboken, NJ: John Wiley & Sons Inc.; 2008.
14. Bakker SJ, Leunissen KM. Hypothesis on cellular ATP depletion and adenosine release as causes of heart failure and vasodilatation in cardiovascular beriberi. Med Hypotheses. 1995 Sep;45(3):265-267.
15. Cintron G, Johnson G, Francis G, Cobb F, Cohn JN. Prognostic significance of serial changes in left ventricular ejection fraction in patients with congestive heart failure. The V-HeFT VA Cooperative Studies Group. Circulation. 1993 Jun;87(6 Suppl):VI17-VI123.
16. Jessup M, Abraham WT, Casey DE, et al. 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation. 2009 Apr 14;119(14):1977-2016. Epub 2009 Mar 26.
17. Krim SR, Campbell P, Lavie CJ, Ventura H. Micronutrients in chronic heart failure. Curr Heart Fail Rep. 2013 Mar;10(1):46-53.
18. Wooley JA. Characteristics of thiamin and its relevance to the management of heart failure. Nutr Clin Pract. 2008 Oct-Nov; 23(5):487-493.
19. Dinicolantonio JJ, Niazi AK, Lavie CJ, O'Keefe JH, Ventura HO. Thiamine supplementation for the treatment of heart failure: a review of the literature. Congest Heart Fail. 2013 Jul;19(4):214-222.